Major funding boost for US FDA drugs programme
This article was originally published in SRA
The US Food and Drug Administration will receive a record $3.2 billion towards salaries and expenses in fiscal year 2010 under an appropriations bill that has been signed into law1,2.
You may also be interested in...
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.